Oral Health in Africa: Promoting Collaborative Solutions

By Crystal Lubbe

April 1, 2025

Is oral health taking a back seat in public health discussions in Africa? This article brings to the forefront the pressing challenges confronting oral health across the continent. Specifically, it highlights the widespread prevalence of untreated dental diseases and the critical shortage of oral health professionals—with the number of dentists ranging from just 1.77 to as few as 0.03 per 10,000 people. Consequently, millions continue to suffer from a high burden of untreated oral conditions, including dental caries, periodontal disease, oral cancers, HIV-related complications, and noma, all of which severely compromise quality of life.

Key Insights:

  • Oral Disease Burden: Untreated dental caries and periodontal disease are widespread in Africa. Regional variations are influenced by socioeconomic and dietary factors.
  • Workforce and Policy Gaps: Many countries face a critical shortage of dentists and dental care assistants. Inadequate oral health policies worsen the problem.
  • Collaborative Solutions: Partnerships among healthcare providers, industry, civil society, and academia are key to improving oral health outcomes.
  • Prevalence of Oral disease: Untreated caries (5+ years) is highest in Northern Africa (33.72%), severe periodontal disease (15+ years) in Western Africa (26.75%), and new lip and oral cavity cancer cases in Northern Africa (median: 269.5 cases). See Table 1 for details.
Table 1: Burden of major oral diseases in Africa (Foláyan et al 2015)

Background Context:

WHO reports Africa has seen the largest global rise in oral diseases over 30 years. Nearly 44% of the population is affected. Only 57% of African countries have a national oral health policy. The region spends less than US$1 per person annually on oral health. WHO’s Global Oral Health Strategy aims for universal coverage by 2030, focusing on prevention and community-based interventions.

Implications:

  • Health Economics: Oral diseases cause significant economic losses due to healthcare costs and lost productivity. Prevention and better care access can bring long-term benefits.
  • Health Outcomes: Integrating oral health into primary healthcare and community interventions can improve overall well-being.
  • Policy and Research: Strengthening local research is vital for evidence-based policies.

To address these issues effectively, stakeholders must take coordinated action. In particular, integrating oral health into national public health policies remains essential for expanding access to care. Furthermore, national dental associations, working in partnership with public health institutions and international organisations, can drive meaningful policy change and promote better resource allocation. Through such collaborative efforts, Africa can begin to close the oral health gap and deliver improved outcomes for its population. For more details, see the original article.

 

Reference url

Recent Posts

suzetrigine pain management
      

Journavx for Pain Management: Toward Affordability and Access

💊 The jury is out on the pricing for Journavx®

Delve into our review of the recent ICER 2025 report on suzetrigine (Journavx®) to learn about the anticipated value relative to its clinical efficacy, safety profile and potential cost savings in tackling acute pain while addressing the opioid crisis.

Explore how suzetrigine paves the way for a safer, more effective approach to pain management and its implications on healthcare economics.

#SyenzaNews #HealthEconomics #HealthcareInnovation #Journavx

defunding scientific research
      

Defunding Scientific Research: Implications and Misconceptions in Gawande’s Analysis of Harvard Funding Cuts

🚨 What happens when scientific research funding is threatened?

In his thought-provoking article, Atul Gawande highlights the dire implications of proposed federal funding cuts to elite institutions like Harvard. He argues that such actions could devastate not just innovation, but also patient care and public health across the nation.

Explore the complexities of research funding and the potential ripple effects on America’s scientific landscape. Don’t miss out on these critical insights!

#SyenzaNews #HealthcareInnovation #HealthEconomics #MarketAccess

perioperative immunotherapy bladder cancer
       

FDA Approves Perioperative Immunotherapy for Bladder Cancer: A Breakthrough in MIBC Treatment

🚀 Are we witnessing a new era in bladder cancer treatment?

The FDA’s recent approval of durvalumab as the first perioperative immunotherapy for muscle-invasive bladder cancer (MIBC) could revolutionize outcomes for patients facing this formidable diagnosis. With significant improvements in event-free survival and overall survival over standard chemotherapy, this groundbreaking treatment offers new hope 🎉.

Curious about how this could shape the future of cancer care? Dive into the full article to uncover the potential impacts on clinical practice and health economics.

#SyenzaNews #oncology #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.